📊 CNS Key Takeaways
Investment Thesis
Cohen & Steers demonstrates strong operational profitability with 32% operating margin and 27.3% ROE, indicating efficient capital deployment in asset management. However, negative operating cash flow of -$120.4M and free cash flow of -$126.4M raise significant concerns about earnings quality and sustainability, suggesting potential working capital issues or unusual non-cash charges that warrant investigation.
CNS Strengths
- Strong operating margin of 32% and net margin of 27.6% indicating pricing power and operational efficiency
- Robust return on equity of 27.3% and ROA of 17.5% demonstrating effective capital allocation
- Revenue growth of 7.5% YoY with maintained profitability showing business resilience
- Zero debt-to-equity ratio providing financial flexibility and low financial risk
CNS Risks
- Significant disconnect between net income ($153.2M) and operating cash flow (-$120.4M) indicating potential earnings quality concerns
- Negative free cash flow of -$126.4M despite profitability suggests unsustainable capital structure or unusual working capital dynamics
- Net income decline of 2.7% YoY despite 7.5% revenue growth indicates margin compression or increased expenses
- High insider activity (17 Form 4 filings) in last 90 days warrants monitoring for potential insider selling pressure
Key Metrics to Watch
- Operating cash flow trend and reconciliation with net income to identify earnings quality issues
- Revenue growth sustainability and margin stability in core asset management business
- Working capital changes and capital deployment decisions given negative FCF
CNS Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
CNS Profitability Ratios
CNS vs Default Sector
How COHEN & STEERS, INC. compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
CNS Balance Sheet & Liquidity
CNS 5-Year Financial Trend
5-Year Trend Summary: COHEN & STEERS, INC.'s revenue has remained relatively flat over the 5-year period, with a 5% decline. The most recent EPS of $2.60 reflects profitable operations.
CNS Growth Metrics (YoY)
CNS Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $133.2M | $39.7M | $0.77 |
| Q2 2025 | $121.7M | $31.8M | $0.63 |
| Q1 2025 | $122.7M | $34.0M | $0.68 |
| Q3 2024 | $123.7M | $32.1M | $0.65 |
| Q2 2024 | $120.6M | $31.8M | $0.63 |
| Q3 2023 | $123.7M | $32.1M | $0.65 |
| Q2 2023 | $120.6M | $31.8M | $0.64 |
| Q1 2023 | $122.7M | $34.0M | $0.68 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
CNS Capital Allocation
CNS SEC Filings
Access official SEC EDGAR filings for COHEN & STEERS, INC. (CIK: 0001284812)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CNS
What is the AI rating for CNS?
COHEN & STEERS, INC. (CNS) has an AI rating of HOLD with 62% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CNS's key strengths?
Strong operating margin of 32% and net margin of 27.6% indicating pricing power and operational efficiency. Robust return on equity of 27.3% and ROA of 17.5% demonstrating effective capital allocation.
What are the risks of investing in CNS?
Significant disconnect between net income ($153.2M) and operating cash flow (-$120.4M) indicating potential earnings quality concerns. Negative free cash flow of -$126.4M despite profitability suggests unsustainable capital structure or unusual working capital dynamics.
What is CNS's revenue and growth?
COHEN & STEERS, INC. reported revenue of $556.1M.
Does CNS pay dividends?
COHEN & STEERS, INC. pays dividends, with $126.9M distributed to shareholders in the trailing twelve months.
Where can I find CNS SEC filings?
Official SEC filings for COHEN & STEERS, INC. (CIK: 0001284812) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CNS's EPS?
COHEN & STEERS, INC. has a diluted EPS of $2.97.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.